Associated Papers
Quantitative thresholds for variant enrichment in 13,845 cases: improving pathogenicity classification in genetic hearing loss.
Liu S et al.
Genome Medicine, 2023
38111038 (PubMed )
Supplement: 13073_2023_1271_MOESM1_ESM.xlsx › Table_S7
Treatment-emergent neuroendocrine prostate cancer with a germline BRCA2 mutation: identification of a candidate reversion mutation associated with platinum/PARP-inhibitor resistance.
Pandya D et al.
Cold Spring Harbor Molecular Case Studies, 2021
Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer.
Tong L et al.
Theranostics, 2019
31534501 (PubMed )
Supplement: thnov09p5532s1.pdf
Low-grade prostate cancer diverges early from high grade and metastatic disease.
VanderWeele DJ et al.
Cancer Science, 2014
24890684 (PubMed )
Supplement: cas0105-1079-SD1.xlsx › Table_S2
Select a paper to view details